Literature DB >> 31297738

Central Giant Cell Granuloma Treated with Intralesional Corticosteroid Injections and Bisphosphonates: A Long-Term Follow-Up Case Study.

Raíssa Pinheiro de Mendonça1, Geovanni Pereira Mitre2, Flavio Henrique Real3, Maria Sueli da Silva Kataoka2, Sérgio de Melo Alves Júnior2, Paulo Vianna4, Newton Guerreiro Da Silva Júnior3, João de Jesus Viana Pinheiro5,6.   

Abstract

Central giant cell granuloma (CGCG) is a benign intraosseous lesion of the head and neck with potential for aggressive and locally destructive behaviour. Lesions of the maxilla tend to expand more than those of the mandible due to the thinner cortices and spongy tissue of this location. Surgical removal is the most common treatment; however, it may be disfiguring in aggressive cases, especially for lesions located in the maxilla. Alternative treatments, such as intralesional corticosteroid injections, have been performed with satisfactory results. We report a case of a 12-year-old female patient with a CGCG of the left maxilla that was treated with 40 doses of intralesional triamcinolone acetonide infiltrations combined with alendronate sodium and calcium carbonate. Clinical and imaging follow-up over 12 years demonstrates improvement in the patient's condition.

Entities:  

Keywords:  Corticosteroid; Giant cell; Granuloma; Injections; Intralesional; Triamcinolone acetonide

Mesh:

Substances:

Year:  2019        PMID: 31297738      PMCID: PMC7235135          DOI: 10.1007/s12105-019-01053-x

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  21 in total

1.  Pharmacological and surgical therapy for the central giant cell granuloma: A long-term retrospective cohort study.

Authors:  Willem Hans Schreuder; Henk van den Berg; Anne Marie Westermann; Zachary Scott Peacock; Jan de Lange
Journal:  J Craniomaxillofac Surg       Date:  2016-12-09       Impact factor: 2.078

2.  Clinical and radiological features of central giant-cell lesions of the jaw.

Authors:  Jan De Lange; Hans P Van den Akker
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2005-04

3.  Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.

Authors:  S Rudge; S Hailwood; A Horne; J Lucas; F Wu; T Cundy
Journal:  Rheumatology (Oxford)       Date:  2005-02-03       Impact factor: 7.580

4.  Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant-cell granuloma in 21 cases.

Authors:  R L M Nogueira; R C Teixeira; R B Cavalcante; R A Ribeiro; S H B Rabenhosrt
Journal:  Int J Oral Maxillofac Surg       Date:  2010-07-31       Impact factor: 2.789

5.  Management of central giant cell granuloma with subcutaneous denosumab therapy.

Authors:  Aparna Naidu; Michael P Malmquist; Claude A Denham; Sterling R Schow
Journal:  J Oral Maxillofac Surg       Date:  2014-07-07       Impact factor: 1.895

6.  Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.

Authors:  Philip N Sambrook; Mark Kotowicz; Peter Nash; Colin B Styles; Vasi Naganathan; Kathy N Henderson-Briffa; John A Eisman; Geoff C Nicholson
Journal:  J Bone Miner Res       Date:  2003-05       Impact factor: 6.741

7.  Combination therapies for the treatment of recurrent central giant cell lesion in the maxilla: a case report.

Authors:  Jefferson Paulo de Oliveira; Fernanda Olivete; Naylin Danyele de Oliveira; Allan Fernando Giovanini; João César Zielak; Leandro Klüppel; Rafaela Scariot
Journal:  J Med Case Rep       Date:  2017-03-20

8.  Central giant cells lesion: Report of a conservative management.

Authors:  Marina Rolo Pinheiro da Rosa; Juliana Lopes de Sá; Valber Barbosa Martins; Marcelo Vinícius de Oliveira
Journal:  Eur J Dent       Date:  2018 Apr-Jun

9.  Treatment of central giant cell lesions using bisphosphonates with intralesional corticosteroid injections.

Authors:  Newton Guerreiro Júnior da Silva; Aline Semblano Dias Carreira; Erick Nelo Pedreira; Fabrício Mesquita Tuji; Karem López Ortega; João de Jesus Viana Pinheiro
Journal:  Head Face Med       Date:  2012-08-22       Impact factor: 2.151

10.  Intralesional corticosteroid injections in the treatment of central giant cell lesions of the jaws: a meta-analytic study.

Authors:  Rafael-Lima-Verde Osterne; Phelype-Maia Araújo; Abrahao-Cavalcante-Gomes de Souza-Carvalho; Roberta-Barroso Cavalcante; Eduardo Sant'Ana; Renato-Luiz-Maia Nongueira
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-03-01
View more
  3 in total

1.  Management of recurrent central giant cell granuloma of mandible using intralesional corticosteroid with long-term follow-up.

Authors:  Kumar Nilesh; Anuj Dadhich; Rahul Patil
Journal:  BMJ Case Rep       Date:  2020-09-14

2.  Intra-Lesional Medicaments for the Management of Intra-Osseous Lesions of Maxilla and Mandible - Systematic Review.

Authors:  Komal Smriti; Evit John; Kalyana-Chakravarthy Pentapati; Srikanth Gadicherla; Manish Bhagania
Journal:  J Int Soc Prev Community Dent       Date:  2020-01-24

Review 3.  Giant Cell Lesions of the Jaws Involving RASopathy Syndromes.

Authors:  Melissa Luna; Nicholas Wolsefer; Carlos-Xavier Zambrano; Ivan James Stojanov
Journal:  Acta Stomatol Croat       Date:  2022-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.